06/05/2016 02:42:39 1-888-992-3836 (toll free) Free Membership Login
Company name:Allergy Thera.
EPIC:AGYTrading Currency:GBX
Market Sector:AIMISIN:GB00B02LCQ05
Market Segment:AIMShare Type:DE
WWW Address:Description:ORD 0.1P
Industry Sector:PHARMACEUTICALS & BIOTECHNOLOGY
 Price Price Change [%] Bid Ask Open High Low Volume
 25.63 mages.advfn.com/imagesnew/2/us/dot 0.0 [0.00] 25.50 25.75 25.63 25.63 25.63 39,174
 Market Cap. [m] Shares In Issue [m] Beta EPS DPS PE Ratio Yield 52-Wks-Range
 150.97 589.16 0.98 0.02 - 1,281.25 - 33.75 - 20.38

Allergy Therapeutics Key Figures

(at previous day's close)
Market Cap.150.97m
Shares In Issue589.16m
Prev. Close25.63
PE Ratio1,281.25 
Dividend Yield-%
EPS - basic0.02p
Dividend PS-p
Dividend Cover- 
Cash Flow PS0.34p
Return On Equity (ROE)0.31%
Operating Margin1.51%
PEG Factor-14.64 
EPS Growth Rate-87.50%
Dividends PS Growth Rate-%
Net Debt-4.97m
Gross Gearing32.01%
Quick Assets26.26m
Net Working Capital25.59m
Intangibles / Fixed Assets28.26%
Turnover PS7.34p
Pre-Tax Profit PS0.11p
Retained Profit PS0.02p
Cash PS3.60p
Net Cash PS2.34p
Net Tangible Asset Value PS *5.00p
Net Asset Value PS5.85p
Spread0.25 (0.97%) 

Allergy Therapeutics Balance Sheet

LSE:AGY:Liabilities+EQLSE:AGY:Assets

Share Price Performance

Sample Period HighLow
1 week26.2525.63
4 weeks27.1325.63
12 weeks28.0025.63
1 year33.7520.38

Share Price Chart (5 years)

Allergy Therapeutics Historic Returns

Giorni da oggi OpenChange%Open Avg.Avg. Daily Vol [m]Total Vol [m]VWAP
1 week26.25-0.63-2.3826.060.0525.89
4 weeks27.13-1.50-5.5326.340.1126.28
12 weeks25.88-0.25-0.9726.520.0926.63
26 weeks31.13-5.50-17.6728.180.1128.26
1 year22.003.6316.4826.570.1527.02
3 years10.1315.50153.0919.750.3216.59
5 years15.889.7561.4216.290.3313.89

Allergy Therapeutics Key Management Ratios

Allergy Therapeutics Investment Ratios

(Market value analysis) at previous day's close
PQ Ratio35.48 
PE Ratio1,281.25 
Tobin's Q Ratio 3.82 
Tobin's Q Ratio (excl. intangibles)4.29 
Dividend Yield-%
Market-to-Book Ratio4.38 
Price-to-Pre-Tax Profit PS230.84 
Price-to-Retained Profit PS1,397.89 
Price-to-Cash Flow PS75.30 
Price-to-Sales PS3.49 
Price-to-Net Tangible Asset Value PS5.12 
Price-to-Cash PS7.12 
Net Working Capital PS4.34 
Price Pct to Working Capital PS5.90%
Earnings Yield0.08%
Average PE323.62 
Years in average4 
PE to PE average395.92%

Allergy Therapeutics Financial Ratios

(Leverage Ratios)
Debt Ratio20.36%
Debt-to-Equity Ratio0.26 
Debt-to-Equity Ratio (excl. Intgbl)0.30 
Debt-to-Equity Market Value0.06 
Net Gearing-9.80%
Net Gearing (excl. Intangibles)-10.87%
Gross Gearing32.01%
Gross Gearing (excl. Intangibles)35.52%
Gearing Under 1 Year14.64%
Gearing Under 1 Year (excl. Intgbl)16.24%
Assets/Equity1.47 
Cash/Equity61.50 
(Liquidity Ratios)
Net Working Capital to Total Assets50.47%
Current Ratio4.45 
Quick Ratio (Acid Test)3.54 
Liquidity Ratio2.86 
Cash & Equiv/Current Assets64.23%
(Solvency Ratios)
Enterprise Value138.58m
CFO/Sales0.05 
CFO/Attributable Profit18.56 
CFO/Assets0.04 
CFO/Debt0.12 
Total Debt/Equity Market Value0.11 
Total Debt/Sales0.38 
Total Debt/Pre-Tax Profit24.82 
Total Debt16.23m
Total Debt/Net Current Assets0.63%
(Dodds - Graham Ratios)
3 yr Compound Earnings Growth-%
5 yr Compound Earnings Growth-%
10 yr Compound Earnings Growth-%
Earn drops > 5% in 10yrs5 
Beta (60-Mnth)Beta (36-Mnth)
0.97841.1598
Alpha (60-Mnth)Alpha (36-Mnth)
0.01970.0428

Allergy Therapeutics Operating Ratios

(Profitability Ratios)
Return On Capital Employed (ROCE)1.51%
Return On Assets (ROA)0.27%
Net Profit Margin0.25%
Assets Turnover1.09 
Return On Equity (ROE)0.31%
Return On Investment (ROI)0.33%
Dividend Payout Ratio-%
Plowback Ratio100.00%
Growth from Plowback Ratio0.44%
Net Income Of Revenues0.25%
(Asset Utilisation Multiples)
Shareholders Equity Turnover1.75 
Fixed Assets Turnover2.70 
Current Assets Turnover1.84 
Net Working Capital Turnover 
Inventory Turnover6.54 
(Other Operating Ratios)
Total Assets-to-Sales0.91 
Debtors-to-Sales12.26%
Debt Collection Period44.76Days

Allergy Therapeutics Dividends

Sorry No Data Available

Allergy Therapeutics Fundamentals

 30 Jun 2012 (GBP)30 Jun 2013 (GBP)30 Jun 2014 (GBP)30 Jun 2015 (GBP)
turnover41.28100.00%39.28100.00%41.96100.00%43.23100.00%m
pre tax profit0.641.55%0.431.10%1.082.58%0.651.51%m
attributable profit0.821.99%0.541.36%0.741.77%0.110.25%m
retained profit0.821.99%0.541.36%0.741.77%0.110.25%m
eps - basic0.25 0.13 0.16 0.02 
eps - diluted0.24 0.13 0.16 0.02 
dividends per share- - - - 

Allergy Therapeutics Balance Sheet

 30 Jun 2012 (GBP)30 Jun 2013 (GBP)30 Jun 2014 (GBP)30 Jun 2015 (GBP)
LSE:AGY:Liabilities+EQLSE:AGY:AssetsLSE:AGY:Liabilities+EQLSE:AGY:AssetsLSE:AGY:Liabilities+EQLSE:AGY:AssetsLSE:AGY:Liabilities+EQLSE:AGY:Assets
 30 Jun 2012 (GBP)30 Jun 2013 (GBP)30 Jun 2014 (GBP)30 Jun 2015 (GBP)
ASSETS
fixed assets fixed assets7.5627.22%7.3425.33%7.0324.76%8.7517.26%m
intangibles intangibles4.6016.56%3.9113.50%3.7713.28%5.009.86%m
fixed investments fixed investments2.579.26%3.0610.57%3.5612.53%3.947.78%m
current assets - other current assets - other0.481.74%--%--%--%m
stocks stocks6.6523.96%6.0120.76%6.4722.78%6.7513.31%m
debtors debtors5.0018.00%7.3925.50%5.5419.52%5.069.98%m
cash & securities cash & securities0.903.25%1.264.34%2.037.14%21.2041.81%m
TOTAL27.75100%28.96100%28.40100%50.70100%m
LIABILITIES
creditors - short creditors - short7.7527.91%7.6226.31%6.4722.80%7.4214.64%m
creditors - long creditors - long5.4219.51%6.6723.04%6.8524.12%8.8117.38%m
creditors - other creditors - other--%--%--%--%m
subordinated loans subordinated loans--%--%--%--%m
insurance funds insurance funds--%--%--%--%m
TOTAL13.1647.42%14.2949.35%13.3246.92%16.2332.01%m
EQUITY
ord cap, reserves ord cap, reserves14.5952.58%14.6750.65%15.0853.08%34.4767.99%m
prefs, minorities prefs, minorities--%--%--%--%m
TOTAL14.5952.58%14.6750.65%15.0853.08%34.4767.99%m
OTHER
NAV Basic- - - - 
NAV Diluted- - - - 

Allergy Therapeutics Cash Flow Statement

30 Jun 2012 (GBP)30 Jun 2013 (GBP)30 Jun 2014 (GBP)30 Jun 2015 (GBP)
Operating CF2.882.432.172.01m
Pre-Financing CF1.311.281.04-0.66m
Retained CF-1.421.421.0419.42m

Allergy Therapeutics Brokers

NameActivityTypeMnemonicCode
Nomura Code Securities LimitedMarket Maker(MMF)Broker/DealerCODECODCGB21
Evolution Securities LimitedMarket Maker(MMF)Broker/DealerEVOEVBGGB21MMT
Canaccord Genuity LimitedMarket Maker(MMF)Broker/DealerCANAHOARGB21001
Jefferies International LtdMarket Maker(MMF)Broker/DealerJEFFJEFFGB2X
Liberum Capital LimitedMarket Maker(MMF)Broker/DealerLIBCLCAPGB21
Piper Jaffray LtdMarket Maker(MMF)Broker/DealerPIPRPIPRGB21
Shore Capital Stockbrokers LtdMarket Maker(MMF)Broker/DealerSCAPSHOCGB21
Winterflood Securities LtdMarket Maker(MMF)Broker/DealerWINSWNTSGB2LBIC


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:32 V:us D:20160506 01:42:39